Kalytera Therapeutics Announces Filing of Amended and Restated Short Form Prospectus
July 26, 2018 08:00 ET
|
Kalytera Therapeutics, Inc.
/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ SAN FRANCISCO and TEL AVIV, Israel, July 26, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (the "Company", or...
Kalytera Therapeutics Announces Short Form Prospectus Offering of Units
July 10, 2018 08:00 ET
|
Kalytera Therapeutics, Inc.
/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ SAN FRANCISCO and TEL AVIV, Israel, July 10, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (the "Company", or...
Kalytera Announces Appointment of Victoria Rudman as Interim Chief Financial Officer and Additional Payments in Shares under Payments Agreements with Salzman Group
June 29, 2018 11:31 ET
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO and TEL AVIV, Israel, June 29, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the "Company" or "Kalytera") today announced the appointment of...
Kalytera Announces Second Payments Agreement with The Salzman Group of Israel
June 15, 2018 14:55 ET
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO and TEL AVIV, Israel, June 15, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the "Company" or "Kalytera") today announced that it has entered...
Kalytera Announces Next Monthly Payment in Shares under Services Agreement with Salzman Group
June 04, 2018 14:01 ET
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO and TEL AVIV, Israel, June 04, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the "Company" or "Kalytera") today announced that the Company has...
Kalytera Announces Next Payment in Shares under Services Agreement with Salzman Group
April 20, 2018 15:08 ET
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO and TEL AVIV, Israel, April 20, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the "Company" or "Kalytera") today announced that the Company has...
Kalytera Announces Next Issuance of Shares under Services Agreement with Salzman Group
March 22, 2018 09:00 ET
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO and TEL AVIV, Israel, March 22, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the "Company" or "Kalytera") today announced that the Company...
Kalytera Announces Grant of Stock Options to Chief Scientific Officer and Chief Medical Officer
March 14, 2018 08:30 ET
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO and TEL AVIV, Israel, March 14, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the "Company" or "Kalytera") today announced that it has granted...
Kalytera Announces Further Issuance of Shares under Services Agreement with Salzman Group
February 23, 2018 08:23 ET
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO and TEL AVIV, Israel, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the "Company" or "Kalytera") today announced that the Company has...
Kalytera Announces Grant of Stock Options
January 31, 2018 08:00 ET
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO and TEL AVIV, Israel, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the "Company" or "Kalytera") today announced that it has granted...